AUA Expert Exchange Podcast: Hereditary Kidney Cancer Syndromes (2024)

Based on the documented need for additional education in kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Hereditary Kidney Cancer Syndromes. To address the educational needs of the urologic care team, we recommend the following topic-specific podcast:

Hereditary Kidney Cancer Syndromes

ACKNOWLEDGEMENTS:

Support provided by an independent educational grant from: 

Merck & Co., Inc. 

Target Audience

  • Urologists

Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Select patients who should undergo genetic testing to identify hereditary kidney cancer syndromes based on appropriate criteria, including family history and clinical presentation.
  2. Implement strategies to address ethical concerns related to genetic testing, such as patient consent, confidentiality, and the potential impact on family members.
  3. Discuss VHL syndrome, including its genetic basis, inheritance pattern, and associated tumors.
  4. Properly diagnose and manage VHL syndrome in clinical practice based on knowledge of novel therapeutic strategies.
  5. Utilize a multidisciplinary approach consisting of urologists, oncologists, geneticists and nephrologists when managing hereditary kidney cancer syndromes.
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Non-Physician Participation
Course opens: 
10/16/2024
Course expires: 
10/16/2025
Rating: 
0

FACULTY DISCLOSURES

NameCompany NameRelationship TypeEnd Date
Ball, Mark W.No relevant financial relationships to disclose
Raman, Jay D.No relevant financial relationships to disclose

 

EDUCATION COUNCIL DISCLOSURES

PDF iconEducation Council Disclosures

COI REVIEW WORK GROUP DISCLOSURES

PDF iconCOI Review Workgroup Disclosures

 

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

AUA ACCREDITATION INFORMATION

Method of Participation: Learners will participate in this online educational activity by listening to the podcasts, answering multiple choice questions, examining patient tools and resources and completing the posttests and evaluations. To claim CME credit for these enduring materials, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 0.50 hours

Release Date: October, 2024
Expiration Date: October, 2025

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of a CME activity are required to disclose to the AUA, as the ACCME-accredited provider, all financial relationships with any ineligible company (formerly commercial interests) during the previous 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The AUA must determine if the individual’s relationships are relevant to the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.

Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification relevant financial relationships that result in of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA PARTICIPANT INFORMATION & POLICIES

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Non-Physician Participation
Please login or register to take this course.